We use cookies to ensure that we give you the best experience on our website Learn more

Jun 19, 2019

MASCC/ISOO Annual Meeting on Supportive Care in Cancer

13 - EFFECT OF AN ELECTRONIC QUALITY CHECKLIST ON PRESCRIPTION PATTERNS OF PROPHYLACTIC ANTIEMETICS AND PAIN-FLARE MEDICATIONS IN THE CONTEXT OF PALLIATIVE RADIOTHERAPY FOR BONE METASTASES

;

antiemetics

pain flare

quality

checklist

Abstract

Abstract

thumbnail

Keywords

antiemetics

pain flare

quality

checklist

Abstract

Purpose: International guidelines are available to guide prescription of antiemetics and pain flare medications in patients receiving palliative radiotherapy for bone metastases, but prescription rates are quite variable. We hypothesized that a simple electronic quality checklist could significantly increase evidence-based use of these medications. Materials and Methods: We implemented an electronic quality checklist item for all patients treated in one center with palliative radiotherapy for lumbar spine bone metastases. We reviewed patients in the 6 months pre- and post-intervention. Patients were stratified according to if they were treated within a dedicated rapid palliative (RPAL) radiotherapy program or not. Chi-square tests were used to compare rates of antiemetic and pain flare medications pre- and post-intervention and RPAL vs not. Results: 375 patients were identified with 11.2% treated in dedicated RPAL program. The proportion of patients treated with prophylactic antiemetics and pain flare medications pre- and post-intervention were respectively 33.0% vs 57.0% (p<0.001) and 27.1% vs 39.5% (p=0.01). The effect for antiemetics and pain flare medications. Comparison of overall prescription rates for antiemetics and pain flare medications between RPAL and non RPAL cohorts were respectively 83.3% vs 39.0% (p<0.001) and 74.0 vs 26.0% (p<0.0001). Conclusions: Our data shows that a relatively simple quality checklist item can have a very significant effect on evidence-based use of antiemetic and pain flare medications in patients treated with palliative radiotherapy for bone metastases. We believe such strategies should be routinely included in other clinical pathways to improve use of symptom control medications.

Discover over 20,000 new abstracts, posters and presentations from leading academic conferences every month. Stay on top of the latest findings, methodologies and discussions happening in your research field around the world.

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.